Incidence, predictors and clinical management of hyperkalaemia in new users of mineralocorticoid receptor antagonists-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Incidence, predictors and clinical management of hyperkalaemia in new users of mineralocorticoid receptor antagonists

Published:2018-04-18 Issue:8 Volume:20 Page:1217-1226
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Trevisan Marco¹,de Deco Pietro²,Xu Hairong³,Evans Marie⁴,Lindholm Bengt⁴,Bellocco Rino¹²,Barany Peter⁴,Jernberg Tomas⁵,Lund Lars H.⁶,Carrero Juan J.¹

Affiliation:

1. Department of Medical Epidemiology and Biostatistics; Karolinska Institutet; Stockholm Sweden

2. Department of Statistics and Quantitative Methods; University of Milano-Bicocca; Milan Italy

3. AstraZeneca; Gaithersburg MD USA

4. Department of Clinical Science, Intervention and Technology; Karolinska Institutet; Stockholm Sweden

5. Department of Clinical Sciences; Danderyd University Hospital, Karolinska Institutet; Stockholm Sweden

6. Department of Medicine; Karolinska Institutet; Stockholm Sweden

Funder

AstraZeneca to Karolinska Institutet

Swedish Heart and Lung Foundation

The Stockholm County Council

Baxter Healthcare

Vifor Fresenius Medical Care Renal Pharma

Martin Rind's and Westman's Foundations

Erasmus Traineeship Program

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ejhf.1199/fullpdf

Reference43 articles.

1. Developed with the special contribution of the Heart Failure Association (HFA) of the ESC;Ponikowski;Eur J Heart Fail,2016

2. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;Yancy;J Am Coll Cardiol,2013

3. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8);James;JAMA,2014

4. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC);Mancia;Eur Heart J,2013

5. Effect of spironolactone on blood pressure in subjects with resistant hypertension;Chapman;Hypertension,2007

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse events associated with early initiation of Eplerenone in patients hospitalized for acute heart failure;International Journal of Cardiology;2024-11

2. GLP-1RA vs DPP-4i Use and Rates of Hyperkalemia and RAS Blockade Discontinuation in Type 2 Diabetes;JAMA Internal Medicine;2024-08-12

3. Factors influencing the efficacy and safety of esaxerenone in hypertensive patients: a pooled analysis of five clinical studies on different comorbidities;Hypertension Research;2024-08-02

4. Serum potassium abnormalities, renin-angiotensin-aldosterone system inhibitor discontinuation, and clinical outcomes in patients with chronic cardiovascular, metabolic, and renal conditions: A population-based analysis;European Journal of Internal Medicine;2024-07

5. Estimated Effect of Restarting Renin-Angiotensin System Inhibitors after Discontinuation on Kidney Outcomes and Mortality;Journal of the American Society of Nephrology;2024-06-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3